Wound Treatments in France

Published by: Euromonitor International

Published: Dec. 1, 2007 - 40 Pages

Table of Contents

OTC HEALTHCARE IN FRANCE

Executive Summary

Slow Growth

De-reimbursement Limited Impact

Pharmacies Stronghold Lessening

Changing Mentalities

Potential Growth

Key Trends and Developments

OTC Products in Difficult Trading Conditions

Demographic Trends Impact Demand

De-reimbursement: Does It Work?

Economic Growth Increases Visits To Private Doctors

Hectic Lifestyles and Rising Health Awareness Drive Sales

Market Indicators

Table 1 Life Expectancy at Birth 2001-2006

Market Data

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 6 Penetration of Private Label by Sector 2002-2006

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

Appendix

OTC Registration and Classification

Advertising

Packaging and Labelling

Distribution

De-listing Or De-reimbursement

Vitamins and Dietary Supplements Registration and Classification

Generics

Consumer Expenditure on Health Goods and Medical Services

Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006

Definitions

Sources

Summary 1 Research Sources

LOCAL COMPANY PROFILES - FRANCE

Arkopharma Sa, Laboratoires Pharmaceutiques

Strategic Direction

Key Facts

Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts

Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006

Company Background

Production

Competitive Positioning

Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006

Beaufour-ipsen SA

Strategic Direction

Key Facts

Summary 5 Beaufour-Ipsen SA: Key Facts

Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006

Company Background

Production

Summary 7 Beaufour-Ipsen SA: Production Statistics 2006

Competitive Positioning

Summary 8 Beaufour-Ipsen SA: Competitive Position 2006

Juva Santé, Laboratoires

Strategic Direction

Key Facts

Summary 9 Juva Santé, Laboratoires: Key Facts

Summary 10 Juva Santé, Laboratoires: Operational Indicators 2004-2006

Company Background

Production

Summary 11 Juva Santé, Laboratoires: Production Statistics 2006

Competitive Positioning

Summary 12 Juva Santé, Laboratoires: Competitive Position 2006

Laboratoires Martin-johnson & Johnson-msd Sas

Strategic Direction

Key Facts

Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts

Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006

Company Background

Competitive Positioning

Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006

Pfizer Santé Grand Public

Strategic Direction

Key Facts

Summary 16 Pfizer Santé Grand Public: Key Facts

Summary 17 Pfizer Santé Grand Public: Operational Indicators 2004-2006

Company Background

Production

Competitive Positioning

Summary 18 Pfizer Santé Grand Public: Competitive Position 2006

Pierre Fabre Sa, Laboratoires

Strategic Direction

Key Facts

Summary 19 Pierre Fabre SA, Laboratoires: Key Facts

Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006

Company Background

Production

Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006

Competitive Positioning

Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006

Théraplix SA

Strategic Direction

Key Facts

Summary 23 Théraplix SA: Key Facts

Summary 24 Théraplix SA: Operational Indicators 2004-2006

Company Background

Competitive Positioning

Summary 25 Théraplix SA: Competitive Position 2006

Upsa, Laboratoires

Strategic Direction

Key Facts

Summary 26 UPSA Conseil SAS: Key Facts

Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006

Company Background

Production

Competitive Positioning

Summary 28 UPSA, Laboratoires: Competitive Position 2006

Urgo, Laboratoires

Strategic Direction

Key Facts

Summary 29 Urgo, Laboratoires: Key Facts

Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006

Company Background

Production

Competitive Positioning

Summary 31 Urgo, Laboratoires: Competitive Position 2006

WOUND TREATMENTS IN FRANCE

Overview

Sector Data

Table 12 Sales of Wound Treatments by Subsector: Value 2001-2006

Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006

Table 14 Wound Treatments Company Shares by Retail Value 2002-2006

Table 15 Wound Treatments Brand Shares by Retail Value 2003-2006

Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011

Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011

Abstract

Euromonitor International's Wound Treatments in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the wound treatments industry
• Identify growth sectors and factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.


Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.